Results 101 to 110 of about 35,475 (187)
Determination of a suitable voriconazole pharmacokinetic model for personalised dosing
Model based personalised dosing (MBPD) is a sophisticated form of individualised therapy, where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to estimate the dose required to reach a target exposure or effect. The choice of which
Playford, EG +3 more
core +1 more source
Purpose We aimed to investigated the influencing risk factors of voriconazole-induced liver injury in Uygur pediatric patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Methods This was a prospective cohort design study.
Ting Zhao +6 more
doaj +1 more source
Javier Martínez-Casanova,1 Nuria Carballo,1 Sonia Luque,1 Luisa Sorli,2 Santiago Grau1 1Pharmacy Department, Hospital del Mar, Barcelona, Spain; 2Infectious Diseases Department, Hospital del Mar, Barcelona, Spain Abstract: Azole antifungals have ...
Santiago Grau +14 more
core +1 more source
Hong Lu,* Yanmei Mao,* Ying Zeng, Pengyu Li, Pan Yan, Qunzhi Shi, Lin Liu Department of Pharmacy, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, People’s Republic of China*These ...
Lu H +6 more
doaj
In clinical practice, antifungal therapy may be switched from fluconazole to voriconazole; such sequential use poses the potential for drug interaction due to cytochrome P450 2C19 (CYP2C19)-mediated inhibition of voriconazole metabolism. This open-label,
Manthena V. Varma +2 more
core +1 more source
Voriconazole is rapidly incorporated.
Arabidopsis seedlings were incubated for the indicated periods of time in ATS media supplemented with 25 µM voriconazole and the in situ contents of voriconazole were quantified by HPLC-DAD analysis. The means and standard deviations were calculated from
Wilfried Schwab (52238) +10 more
core +1 more source
Voriconazole-Induced acute interstitial pulmonary edema with angioedema: A case report
Background Voriconazole is a first-line antifungal agent for invasive fungal infections. Reports of voriconazole-induced interstitial pulmonary edema are exceedingly rare.
Yuzhen Jin +4 more
doaj +1 more source
Itraconazole is the recommended first-line antifungal agent in blastomycosis treatment. However, pharmacokinetic limitations and adverse drug events may necessitate the use of alternative antifungal agents.
Caitlin C. Schanz +8 more
doaj +1 more source
Hyewon Chung,1,* Howard Lee,1,2,* HyeKyung Han,1 Hyungmi An,1 Kyoung Soo Lim,1,3 YongJin Lee,4 Joo-Youn Cho,1 Seo Hyun Yoon,1 In-Jin Jang,1 Kyung-Sang Yu1 1Department of Clinical Pharmacology and Therapeutics, Seoul National University College of ...
Jang IJ +9 more
core
Drug interactions with voriconazole
Drug interactions are a potential problem with voriconazole therapy, due to the antifungal's extensive interaction with human cytochrome P450 enzymes and transporters.
VIALE, PIERLUIGI, LEWIS, RUSSEL EDWARD
core

